144 related articles for article (PubMed ID: 1721307)
21. Combined liver-kidney transplantation: our experience.
Torregrosa JV; Iñigo P; Navasa M; Rimola A; Grande L; Oppenheimer F
Transplant Proc; 1999 Sep; 31(6):2308. PubMed ID: 10500591
[No Abstract] [Full Text] [Related]
22. Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients.
Koefoed-Nielsen PB; Jørgensen KA
Transplant Proc; 2002 Aug; 34(5):1743-4. PubMed ID: 12176559
[No Abstract] [Full Text] [Related]
23. Tacrolimus: immunosuppression following liver and kidney transplant.
Clark W
J Clin Pharm Ther; 1996 Jun; 21(3):135-41. PubMed ID: 8873845
[TBL] [Abstract][Full Text] [Related]
24. Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group.
Transplant Proc; 1991 Dec; 23(6):3085-8. PubMed ID: 1721367
[No Abstract] [Full Text] [Related]
25. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
Zeevi A; Eiras G; Burckart G; Jain A; Kragack A; Venkataramanan R; Todo S; Fung J; Starzl TE; Duquesnoy RJ
Transplant Proc; 1990 Feb; 22(1):60-3. PubMed ID: 1689902
[No Abstract] [Full Text] [Related]
26. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
27. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
[TBL] [Abstract][Full Text] [Related]
28. Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin.
Neuhaus PJ
Transplant Proc; 1994 Dec; 26(6):3264-6. PubMed ID: 7527961
[No Abstract] [Full Text] [Related]
29. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
[No Abstract] [Full Text] [Related]
30. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
[No Abstract] [Full Text] [Related]
31. Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients.
Manzanares C; Moreno M; Castellanos F; Cubas A; Herrero JC; Morales-Ruiz E; Segura J; Andres A; Morales JM
Transplant Proc; 1998 Jun; 30(4):1264-5. PubMed ID: 9636513
[No Abstract] [Full Text] [Related]
32. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
Brunet M; Torregrosa JV; Oppenheimer F; Corbella J
Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
[No Abstract] [Full Text] [Related]
33. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
[TBL] [Abstract][Full Text] [Related]
34. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
Becker G; Witzke O; Friedrich J; Wagner K; Heemann U; Philipp T
Transplant Proc; 1996 Dec; 28(6):3169-70. PubMed ID: 8962228
[No Abstract] [Full Text] [Related]
37. Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients.
Transpl Int; 1992; 5 Suppl 1():S552-5. PubMed ID: 14621874
[TBL] [Abstract][Full Text] [Related]
38. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression.
Winkler M; Ringe B; Baumann J; Loss M; Wonigeit K; Pichlmayr R
Clin Chem; 1994 Dec; 40(12):2247-53. PubMed ID: 7527306
[TBL] [Abstract][Full Text] [Related]
39. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
Lang M; Kahl A; Bechstein WO; Neumann U; Settmacher U; Frei U; Neuhaus P
Transplant Proc; 1998 Aug; 30(5):1865-7. PubMed ID: 9723313
[No Abstract] [Full Text] [Related]
40. Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
McMichael J; Irish W; McCauley J; Shapiro R; Gordon R; Van Thiel DH; Lieberman R; Warty VS; Fung J; Starzl TE
Transplant Proc; 1991 Dec; 23(6):2780-2. PubMed ID: 1721275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
